继发性甲状旁腺功能亢进

  • 网络secondary hyperparathyroidism;SHPT;secondary hyperparathyroidism,SHPT;Secondary hyperparathyroidism SHPT
继发性甲状旁腺功能亢进继发性甲状旁腺功能亢进
  1. 目的探讨甲状旁腺细胞增生和凋亡在严重肾性继发性甲状旁腺功能亢进(SHPT)发病机制中的作用。

    Objective To study the effect of parathyroid cells proliferation and apoptosis in severe renal secondary hyperparathyroidism ( SHPT ) .

  2. 甲状旁腺切除术治疗继发性甲状旁腺功能亢进

    Parathyroidectomy in the treatment of patients with secondary hyperparathyroidism

  3. 小剂量1,25(OH)2D3口服冲击治疗尿毒症患者继发性甲状旁腺功能亢进

    Pulse therapy of low dose oral 1,25 ( OH ) 2D 3 in uremic patients with second hyperparathyroidism

  4. ~(99m)Tc-MIBI双时相显像对继发性甲状旁腺功能亢进的临床价值

    Clinical value of dual-phase ~ ( 99m ) Tc-MIBI scintigraphy in secondary hyperparathyroidism

  5. 目的:了解慢性肾功能衰竭继发性甲状旁腺功能亢进症(简称慢性肾衰继发性甲旁亢)患者对红细胞生成素(EPO)疗效的影响。

    Objective : To explore the effect of erythropoietin ( EPO ) on patients of chronic renal failure with hyperparathyroidism .

  6. 目的评价阿法迪三犤1α-(OH)-D3犦每日或冲击治疗血液透析患者继发性甲状旁腺功能亢进(甲旁亢)的有效性和安全性。

    Objective To investigate the efficacy and safety of a treatment protocol involving alfacalcidol ( 1 α ( OH ) D3 ) pulse versus daily therapy in treating secondary hyperparathyroidism in maintenance hemodialysis patients .

  7. 目为探讨α骨化醇(1α-(OH)D3,霜叶红)治疗慢性肾衰引起继发性甲状旁腺功能亢进的疗效。

    Objective To investigate the effects of oral 1 a - ( OH ) D3 on secondary hyperparathyroidism in chronic renal failure patients with dialysis or non - dialysis .

  8. 结论:活性维生素D3治疗可明显改善维持性血透患者的左心室肥厚,此作用与其改变继发性甲状旁腺功能亢进有关。

    Conclusions : The 1.25-dihydroxyvitamin D 3 treatment can improve LVH significantly in MHD patients , and it may be due to the improvement of secondary hyperparathyroidism .

  9. 目的:了解高频彩超、CT、99mTc甲氧基异丁基异晴(MIBI)双时相平面显像核医学对尿毒症继发性甲状旁腺功能亢进(SHPT)患者甲状旁腺检查的敏感性和特异性。

    Objective : To investigate the sensitivities and specificities of high-frequency color doppler ultrasonography , thin layer CT enhancing scan and 99m Tc-MIBI biphasic scintigraphy in diagnosis of secondary hyperparathyroidism ( SHPT ) in uremia patients .

  10. 血清PTH-M测定诊断271例慢性肾衰致继发性甲状旁腺功能亢进

    Clinical application of serum PTH m determination in diagnosis of secondary hyperparathyroidism induced by chronic renal failure

  11. 甲状旁腺激素测定在继发性甲状旁腺功能亢进手术中的临床应用

    Clinical application of intraoperative parathyroid hormone assay during parathyroidectomy for secondary hyperparathyroidism

  12. 骨化三醇冲击治疗血液透析患者继发性甲状旁腺功能亢进的疗效

    Effects of calcitriol pulse therapy in patients with secondary hyperparathyroidism undergoing hemodialysis

  13. 常规和冲击剂量的阿法D3治疗尿毒症继发性甲状旁腺功能亢进

    Routine and pulse dosage alpha d_3 therapy for uremia patients with secondary hyperparathyroidism

  14. 三种影像学检查方法对诊断继发性甲状旁腺功能亢进的意义

    Diagnosis value of secondary hyperparathyroidism with three imaging methods

  15. 纠正继发性甲状旁腺功能亢进对肾性贫血的影响

    Effects of secondary hyperparathyroidism treatment on renal anemia

  16. 血液透析患者血清铜兰蛋白与钙磷代谢及继发性甲状旁腺功能亢进

    The relationship between serum ceruloplasmin , calcium and phosphorus metabolism and secondary hyperparathyroidism in hemodialysis patients

  17. 目的观察血液灌流比较血液透析滤过对慢性肾衰竭维持血液透析患者继发性甲状旁腺功能亢进的影响。

    Objective To observe the impact of hemoperfusion on chronic renal failure patients with secondary hyperparathyroidism maintaining hemodialysis .

  18. 术中甲状旁腺激素测定监测继发性甲状旁腺功能亢进次全切除术

    Surgical removal of the thyroid gland . Intraoperative parathyroid hormone assay monitoring during subtotal parathyroidectomy in secondary hyperparathyroidism

  19. 实际上是伴有腺体扩大的继发性甲状旁腺功能亢进,它是由慢性肾衰血磷排泄障碍所致。

    This is actually " secondary hyperparathyroidism " with enlarged glands as a consequence of chronic renal failure with impaired phosphate excretion .

  20. 血液灌流对血脂和继发性甲状旁腺功能亢进的影响血清胆红素及血脂水平与冠状动脉病变程度相关性研究

    Effect of Hemoperfusion on the Lipids in Hemodialysis Patients ; The relationship between serum bilirubin , blood lipid and coronary artery stenosis

  21. 目的:观察低钙透析联合罗钙全冲击治疗对维持性血透患者继发性甲状旁腺功能亢进的疗效和安全性。

    Objective : To observe the curative effects and safety of Rocal pulse therapy combined with low calcium dialysis in patients with secondary hyperparathyroidism undergoing haemodialysis .